Among the retinal disorders being studied by scientists at Doheny Eye Institute are age-related macular degeneration (AMD), diabetic retinopathy (DR), retinitis pigmentosa (RP), retinal central vein occlusion, and retinopathy of prematurity.
Researchers are finding new ways to prevent, treat, and cure retinal disorders. These range from nutritional therapies to stem cell therapies. The nutritional therapies, for some forms of AMD, help patients who are at a mid-range stage of the disease. The stem cell therapies are designed to repair the retinal floor, called the retinal pigment epithelium, which malfunctions in many retinal degenerative disorders.
A specialized program at Doheny Eye Institute called the Doheny Image Reading Center (DIRC) is critically important to the worldwide vision research community. DIRC receives photographic images of the retinas of patients with retinal disorders at various stages; the DIRC scientists analyze and report on the images; the reports help scientists and medical doctors evaluate the effects of standard and experimental therapies on the progression of patients’ retinal disease.
Zhihong (Jewel) Hu, PhD
The real and exciting advances that AI offers in medicine matter because they mean we can more quickly diagnose, and precisely treat, our patients.
The work of the Doheny Imaging Reading Center (DIRC) here at the Doheny Eye Institute can be very personally meaningful –for patients we treat here, and for those patients around the world whose images we analyze.